PFIZER has alerted the regulator to an anticipated shortage of high-strength Bicillin L-A (benzathine benzylpenicillin tetrahydrate) 1.2 million unit prefilled syringe for injection from 20 Dec to 10 Jan 2025.
The TGA has approved an alternative overseas-registered product which is now currently available and is PBS-listed.
It is supplied as a powder that needs reconstitution before administration.
The TGA recommends pharmacists order the replacement product as soon as possible to prevent a gap in supply.
The ongoing shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) 600,000 unit prefilled syringes for injection is expected to continue until Apr 2025.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Nov 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Nov 24
